Equities research analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Tuesday. The ...

StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report report ...

A U.S. bankruptcy court rejected the U.S. Justice Department's arguments that Sorrento Therapeutics (OTC:SRNEQ) misrepresented its business location using a P.O. box in Texas in its Chapter 11 ...

2025 Sponsored Scilex Holding Company Announces That The Official Committee Of Unsecured Creditors Of Sorrento Therapeutics, Inc., Has Filed A Motion With The U.S. Bankruptcy Court To Extend The ...

Holdingannounced that the U.S. Bankruptcy Court for the Southern District of Texas has extended the expiration of the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

His background includes positions with NexImmune, Sorrento Therapeutics (OTC:SRNE), and several other biotechnology firms. He is also an accomplished author and patent holder in the field.

Dr. Jerome Zeldis and Dr. Blythe Sather bring exceptional backgrounds in cell therapy and solid tumorsCAMBRIDGE, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERNA), a leader in cell therapies ...

Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any ...